VOICED : La patronal venezolana propone pagar las vacunas anticovid de sus trabajadores

VOICED : La patronal venezolana propone pagar las vacunas anticovid de sus trabajadores

Assessment

Interactive Video

Business, Social Studies, Other

9th - 10th Grade

Hard

Created by

Quizizz Content

FREE Resource

The Venezuelan private sector, led by Fede Cámaras, proposed funding the vaccination of employees and their families. The program, pending government approval, involves importing and distributing vaccines through private clinics. It aims to provide 80% of vaccines at no cost to participating companies' workers, with the rest managed by authorities. The program plans to import 750,000 vaccines biweekly, prioritizing healthcare workers and those over 55. The vaccines include Sputnik V and Sinopharm, with state collaboration expected. Venezuela has declined AstraZeneca vaccines reserved via COVAX.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the main goal of the proposed vaccination program for Venezuelan private industry employees?

To vaccinate employees and their families at no cost

To prioritize only health workers

To reduce the cost of vaccines for the government

To import vaccines from multiple countries

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

How many doses are planned to be imported in the first batch of the vaccination program?

Three million doses

Nine million doses

Six million doses

Twelve million doses

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the estimated cost of the vaccination program?

50 million dollars

75 million dollars

100 million dollars

Over 100 million dollars

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which groups are prioritized in the vaccination program?

Children and teenagers

Health workers and people over 55

All citizens equally

Government officials

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which vaccine has Venezuela decided not to receive through the COVAX mechanism?

Pfizer

AstraZeneca

Sputnik V

Sinopharm